These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20417568)

  • 21. Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy.
    Votruba M; Thiselton D; Bhattacharya SS
    Br J Ophthalmol; 2003 Jan; 87(1):48-53. PubMed ID: 12488262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of autosomal dominant WFS1-associated optic neuropathy and its comparability to OPA1-associated autosomal dominant optic atrophy.
    de Muijnck C; Haer-Wigman L; van Everdingen JAM; Lushchyk T; Heutinck PAT; van Dooren MF; Kievit AJA; Verhoeven VJM; Simon MEH; Wasmann RA; Notting IC; De Baere E; Walraedt S; De Zaeytijd J; Van den Broeck F; Leroy BP; Boon CJF; van Genderen MM
    Sci Rep; 2024 Oct; 14(1):22956. PubMed ID: 39363032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy.
    Kane MS; Alban J; Desquiret-Dumas V; Gueguen N; Ishak L; Ferre M; Amati-Bonneau P; Procaccio V; Bonneau D; Lenaers G; Reynier P; Chevrollier A
    J Cell Mol Med; 2017 Oct; 21(10):2284-2297. PubMed ID: 28378518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
    Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mutation in the OPA1 gene in a Japanese patient with optic atrophy.
    Shimizu S; Mori N; Kishi M; Sugata H; Tsuda A; Kubota N
    Am J Ophthalmol; 2003 Feb; 135(2):256-7. PubMed ID: 12566046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dominant optic atrophy: Culprit mitochondria in the optic nerve.
    Lenaers G; Neutzner A; Le Dantec Y; Jüschke C; Xiao T; Decembrini S; Swirski S; Kieninger S; Agca C; Kim US; Reynier P; Yu-Wai-Man P; Neidhardt J; Wissinger B
    Prog Retin Eye Res; 2021 Jul; 83():100935. PubMed ID: 33340656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.
    Amati-Bonneau P; Valentino ML; Reynier P; Gallardo ME; Bornstein B; Boissière A; Campos Y; Rivera H; de la Aleja JG; Carroccia R; Iommarini L; Labauge P; Figarella-Branger D; Marcorelles P; Furby A; Beauvais K; Letournel F; Liguori R; La Morgia C; Montagna P; Liguori M; Zanna C; Rugolo M; Cossarizza A; Wissinger B; Verny C; Schwarzenbacher R; Martín MA; Arenas J; Ayuso C; Garesse R; Lenaers G; Bonneau D; Carelli V
    Brain; 2008 Feb; 131(Pt 2):338-51. PubMed ID: 18158317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations.
    Cohn AC; Toomes C; Potter C; Towns KV; Hewitt AW; Inglehearn CF; Craig JE; Mackey DA
    Am J Ophthalmol; 2007 Apr; 143(4):656-62. PubMed ID: 17306754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling autosomal dominant optic atrophy associated with OPA1 variants in iPSC-derived retinal ganglion cells.
    Sladen PE; Jovanovic K; Guarascio R; Ottaviani D; Salsbury G; Novoselova T; Chapple JP; Yu-Wai-Man P; Cheetham ME
    Hum Mol Genet; 2022 Oct; 31(20):3478-3493. PubMed ID: 35652445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations.
    Lodi R; Tonon C; Valentino ML; Manners D; Testa C; Malucelli E; La Morgia C; Barboni P; Carbonelli M; Schimpf S; Wissinger B; Zeviani M; Baruzzi A; Liguori R; Barbiroli B; Carelli V
    Arch Neurol; 2011 Jan; 68(1):67-73. PubMed ID: 20837821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between visual acuity and OCT-measured retinal nerve fiber layer thickness in a family with ADOA and an OPA1 mutation.
    Russo A; Delcassi L; Marchina E; Semeraro F
    Ophthalmic Genet; 2013; 34(1-2):69-74. PubMed ID: 22779427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy.
    Nolli C; Goffrini P; Lazzaretti M; Zanna C; Vitale R; Lodi T; Baruffini E
    Mitochondrion; 2015 Nov; 25():38-48. PubMed ID: 26455272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations.
    Ito Y; Nakamura M; Yamakoshi T; Lin J; Yatsuya H; Terasaki H
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4079-86. PubMed ID: 17724190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel mutation of the OPA1 gene in a Japanese family with optic atrophy type 1.
    Shimizu S; Mori N; Kishi M; Sugata H; Tsuda A; Kubota N
    Jpn J Ophthalmol; 2002; 46(3):336-40. PubMed ID: 12063046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families.
    Pretegiani E; Rosini F; Rufa A; Gallus GN; Cardaioli E; Da Pozzo P; Bianchi S; Serchi V; Collura M; Franceschini R; Bianchi Marzoli S; Dotti MT; Federico A
    J Neurol Sci; 2017 Nov; 382():29-35. PubMed ID: 29111013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier.
    Bonifert T; Karle KN; Tonagel F; Batra M; Wilhelm C; Theurer Y; Schoenfeld C; Kluba T; Kamenisch Y; Carelli V; Wolf J; Gonzalez MA; Speziani F; Schüle R; Züchner S; Schöls L; Wissinger B; Synofzik M
    Brain; 2014 Aug; 137(Pt 8):2164-77. PubMed ID: 24970096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiology and ocular blood flow in a family with dominant optic nerve atrophy and a mutation in the OPA1 gene.
    Gränse L; Bergstrand I; Thiselton D; Ponjavic V; Heijl A; Votruba M; Andréasson S
    Ophthalmic Genet; 2003 Dec; 24(4):233-45. PubMed ID: 14566653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy.
    Caporali L; Magri S; Legati A; Del Dotto V; Tagliavini F; Balistreri F; Nasca A; La Morgia C; Carbonelli M; Valentino ML; Lamantea E; Baratta S; Schöls L; Schüle R; Barboni P; Cascavilla ML; Maresca A; Capristo M; Ardissone A; Pareyson D; Cammarata G; Melzi L; Zeviani M; Peverelli L; Lamperti C; Marzoli SB; Fang M; Synofzik M; Ghezzi D; Carelli V; Taroni F
    Ann Neurol; 2020 Jul; 88(1):18-32. PubMed ID: 32219868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.
    Lee J; Jung SC; Hong YB; Yoo JH; Koo H; Lee JH; Hong HD; Kim SB; Chung KW; Choi BO
    Mol Med Rep; 2016 Jul; 14(1):33-40. PubMed ID: 27150940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy.
    Toomes C; Marchbank NJ; Mackey DA; Craig JE; Newbury-Ecob RA; Bennett CP; Vize CJ; Desai SP; Black GC; Patel N; Teimory M; Markham AF; Inglehearn CF; Churchill AJ
    Hum Mol Genet; 2001 Jun; 10(13):1369-78. PubMed ID: 11440989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.